Several reports have shown that PPAR agonists can reverse damaged barrier function in atopic dermatitis-like model; for example, Chiba and Yoshida found that topical application of a PPAR-α agonist and DHA can treat AD in NC/Nga mouse models [27,28]. The gene discussed is PPARA; the disease is atopic eczema.